PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17297011-1 2007 We report 2 cases of traumatic arteriovenous fistulas in the neck treated with transarterial embolization with n-butyl-2-cyanoacrylate (n-BCA). Enbucrilate 111-134 B cell linker Homo sapiens 138-141 26038380-0 2015 Targeted epidural patch with n-butyl cyanoacrylate (n-BCA) through a single catheter access site for treatment of a cerebral spinal fluid leak causing spontaneous intracranial hypotension. Enbucrilate 29-50 B cell linker Homo sapiens 54-57 25845812-2 2015 This study retrospectively reviewed our experience using n-butyl cyanoacrylate (n-BCA) to identify the factors for effective devascularization and procedure-related complications. Enbucrilate 57-78 B cell linker Homo sapiens 82-85 26047904-0 2016 Targeted epidural patch with n-butyl cyanoacrylate (n-BCA) through a single catheter access site for treatment of a cerebral spinal fluid leak causing spontaneous intracranial hypotension. Enbucrilate 29-50 B cell linker Homo sapiens 54-57 26047904-2 2016 We report the first description of a case of SIH caused by a CSF leak which improved after a targeted epidural patch with n-butyl cyanoacrylate (n-BCA) at the right T1-T2 level. Enbucrilate 122-143 B cell linker Homo sapiens 147-150 26038380-2 2015 We report the first description of a case of SIH caused by a CSF leak which improved after a targeted epidural patch with n-butyl cyanoacrylate (n-BCA) at the right T1-T2 level. Enbucrilate 122-143 B cell linker Homo sapiens 147-150 21257203-10 2011 We present here a case of an LSA aneurysm that was successfully embolized with n-butyl cyanoacrylate (n-BCA) with no recurrence after 1 year of follow-up. Enbucrilate 79-100 B cell linker Homo sapiens 104-107 21990781-1 2011 OBJECTIVE AND IMPORTANCE: Currently, n-butyl cyanoacrylate (n-BCA) is one of the most widely used liquid embolic agents in the treatment of intracranial arteriovenous malformations (AVMs). Enbucrilate 37-58 B cell linker Homo sapiens 62-65